Simvastatin Tablets recalled over manufacturing violations
- Recall date
- March 18, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Aurobindo Pharma USA Inc. recalls Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, N…
- Recall number
- D-1234-2020
- FDA classification
- Class II
- Brand / firm
- Aurobindo Pharma USA Inc.
- Sold / distributed
- Nationwide within the United States
Why it was recalled
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-053-90
Get recall alerts
Free email alert whenever Aurobindo Pharma USA Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurobindo Pharma USA Inc.